Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: Evidence for enhanced somatostatinergic tone

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 3, 2000, Pages 1310-1315

  Terzolo, Massimo ^a   Bossoni, Simonetta ^b   Alí, Anna ^a   Doga, Mauro ^b   Reimondo, Giuseppe ^a   Milani, Gabriella ^b   Peretti, Paola ^a   Manelli, Filippo ^b   Angeli, Alberto ^a   Giustina, Andrea ^b,c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c SPEDALI CIVILI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CORTICOTROPIN; DEXAMETHASONE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; SOMATOMEDIN C; SOMATOSTATIN;

ADRENAL CORTEX ADENOMA; ADRENAL SCINTISCANNING; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CUSHINGOID SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIABETES MELLITUS; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNORADIOMETRIC ASSAY; MALE; OBESITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SINGLE BLIND PROCEDURE;

EID: 17744390551     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.3.6531     Document Type: Article

References (35)

1. Incidentally discovered adrenal masses
2. Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumours admitted to a single medical center (1951 to 1978)
3. Does the corticoadrenal adenoma with pre-Cushing syndrome exist?
4. Incidentally discovered ACTH-dependent adrenal adenoma presenting as "pre-Cushing's syndrome."
5. Preclinical Cushing's syndrome in adrenal "incidentalomas:" Comparison with adrenal Cushing's syndrome
6. Epidemiology of Cushing's syndrome and subclinical disease
7. Subclinical Cushing's syndrome in adrenal incidentaloma
8. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)
9. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the humans
10. Human pancreatic growth hormone releasing hormone fails to stimulate human growth hormone both in Cushing's disease and in Cushing's syndrome due to adernocortical adenoma
11. Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects
12. The role of glucocorticoids in the regulation of growth hormone secretion
13. Comparison of the effects of growth hormone releasing hormone and hexarelin, a novel growth hormone releasing peptide analog, on growth hormone secretion in humans with or without glucocorticoid excess
14. Effects of pyridostigmine on spontaneous and growth-hormone releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation
15. Pyridostigmine enhances evin if it does not normalize the growth responses to growth hormone releasing hormone in patients with Cushing's disease
16. Arginine normalize the growth hormone (GH) response to GH-releasing hormone in adults patients receiving chronic daily immunosuppressive glucocorticoid therapy
17. Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly
18. Effect of GHRP-6 and GHRH on GH secretion in rats following chronic glucocorticoid treatment
19. Prevalence of adrenal carcinoma among incidentally discovered adrenal masses
20. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values
21. Scintigrafic evaluation of clinically silent adrenal masses
22. The Cushing's syndrome: An update on diagnostic tests
23. Clinical review 50: Clinically silent adrenal masses
24. Subclinical hormone secretion by incidentally discovered adrenal masses
25. Imaging in endocrinology. The adrenal gland
26. Classification of silent adrenal masses: Time to get practical
27. Abnormalities of endocrine function in patients with clinically "silent" adrenal masses
28. Subclinical Cushing's syndrome in patients with adrenal gland incidentalomas. Pitfalls in diagnosis and management
29. Pre-clinical Cushing's syndrome: Report of three cases and literature review
30. Galanin counteracts the inhibitory effects of glucocorticoids on growth hormone secretion in the rat
31. Responses of plasma ACTH, GH, LH, and 11-hydroxycorticosteroids to various stimuli in patients with Cushing's syndrome
32. Cushing's disease with intermittent hypercortisolism
33. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours
34. Glucose tolerance in patients with an adrenal incidentaloma
35. Altered bone mass and turnover in female patients with adrenal incidentaloma: The effect of subclinical hypercortisolism